HIV & Black communities — understanding the disparities.

There is a version of this subject that gets told constantly and explains nothing. It goes: Black communities have more HIV, therefore something about Black communities must be different. It never says what. And because it only gestures, it leaves the reader holding a vague sense of blame with no useful information attached.

Research challenges explanations that blame Black communities. A 2012 meta-analysis found greater odds of HIV among Black men who have sex with men in the U.S., despite several lower reported behavioral exposures. The authors identified major disparities in structural barriers, partner characteristics, and care. Research on women likewise examines social conditions and sexual networks; it does not establish that one neighborhood factor outweighs every individual exposure.65

What the evidence points to is structure: the density of HIV inside a sexual network segregation has already closed off, the churn mass incarceration puts into partnerships, the distance to a clinic, the insurance card you do or do not have, and whether the doctor in front of you has ever mentioned PrEP. All of those can be changed. That is the point of naming them.

The numbers, stated plainly

In 2024 there were 38,793 new HIV diagnoses in the United States and seven territories and freely associated states, among people aged 13 and older (provisional data). Black/African American people accounted for 15,128 — 39% of all diagnoses, from 12% of the population — with a U.S.-only diagnosis rate of 42.2 per 100,000, the highest of any racial or ethnic group.1

The burden compounds at every later stage. Of the roughly 1.1 million people living with diagnosed HIV at the end of 2024, 446,585 — 39% — were Black; of HIV-related deaths that year, 1,741 (41%) were among Black people.1 Diagnosis disparity becomes prevalence disparity becomes mortality disparity, which is what happens when a gap is never closed at the front end.

Lifetime risk — the figure that reframes everything

CDC’s 2017 lifetime-risk paper used 2010–2014 diagnosis and mortality data to estimate 1 in 22 for Black men, 1 in 54 for Black women, and 1 in 941 for White women under the model’s assumptions. A separate analysis presented in 2016 used 2009–2013 data and projected 1 in 2 for Black men who have sex with men, 1 in 4 for Latino men in that group if diagnosis rates persisted. These are historical population projections, not current individual predictions.3

A historical lifetime projection is not a personal forecast. The model assumed the rates used in its calculation would continue. Prevention, treatment, testing, and changing conditions can alter those rates. The figures show the scale of past disparity without fixing anyone’s future.

Geography is part of the number

Half the U.S. epidemic sits in one region. The South accounted for 19,785 of 2024's diagnoses — 51% — and 53% of HIV-related deaths, while holding roughly 38% of the national population.1 That concentration overlaps with where Black Americans live — a consequence, not a coincidence: the South is where Medicaid expansion has been most limited, clinic closures most concentrated, and the geography of segregation most intact.

Understanding disparities — what the research shows

Individual behavior alone does not explain the disparity

In 2012, Gregorio Millett and colleagues published a meta-analysis in The Lancet pooling 194 studies covering 106,148 Black gay and bisexual men and 581,577 other gay and bisexual men across the United States, Canada, and the United Kingdom. The findings were the opposite of the folk explanation.6

Black gay and bisexual men in the U.S. were no more likely than other gay and bisexual men to report condomless sex with a partner of different HIV status. They reported less substance use (odds ratio 0.67, 95% CI 0.50–0.92). They were more likely to report any preventive behavior at all (OR 1.39, 1.23–1.57). And they were three times the odds of living with HIV (OR 3.00, 2.06–4.40).6

Where the differences were largest was structural: Black gay and bisexual men had roughly twofold greater odds of any structural barrier — unemployment, low income, previous incarceration, less education — and were markedly less likely to have health insurance, to have started antiretroviral therapy, or to be virally suppressed. Millett's summary: disparities were greatest for structural barriers, partner demographics, and care outcomes, and smallest for sexual risk behavior.6 An Atlanta cohort found the same locally: 43% HIV prevalence among Black participants versus 13% among white participants, with Black participants reporting fewer partners and less drug use while living in census tracts with higher poverty.6

Why networks matter more than partner counts

Adaora Adimora and Victor Schoenbach at the University of North Carolina have spent two decades building out the mechanism. Their argument is that the same sexual behavior carries different consequences depending on the structure of the network it occurs in — and that network structure is shaped by forces well outside anyone's bedroom.5

Two pieces of that work matter most here. First, concurrency: using mathematical modeling, Adimora and Schoenbach showed that overlapping partnerships spread HIV through a network far more efficiently than the same number of partnerships arranged one after another, because concurrency removes the delay that serial monogamy imposes on onward transmission.5 Second, context: they identify poverty, discrimination, the local drug economy, the male-to-female sex ratio, incarceration rates, and racial residential segregation as forces that shape network structure both directly and indirectly.5

Why this framing is not just politeness

Getting this right has practical consequences. If the problem is behavior, the intervention is education and exhortation — and forty years of that has not closed the gap. If the problem is network density, access, and trust, the interventions are testable: treat everyone in the network so viral loads drop, put PrEP where people already are, pay peer navigators, fund Black-led clinics, expand Medicaid, decarcerate.

The history you were not taught

Ryan White's story is the one most Americans know, and it mattered enormously. But the epidemic in Black America has its own leaders and its own turning points, largely absent from the popular telling.

1983 — the Denver Principles

In June 1983, at the National Lesbian and Gay Health Conference in Denver, a small advisory committee of people with AIDS drafted a manifesto that reset the terms of the response. The Denver Principles rejected being labeled as passive or defeated, insisted on the phrase "People With AIDS," and asserted a set of rights — including the right to "quality medical treatment and quality social service provision without discrimination of any form including sexual orientation, gender, diagnosis, economic status or race."10

That last clause — or race — was written in 1983. It was already clear to the people living it that this epidemic would not be distributed evenly. Later global frameworks on the meaningful involvement of people living with HIV trace back to that document.10

1985 — Us Helping Us begins in a living room

In 1985, the same year he learned he was living with HIV, Bishop Kwabena "Rainey" Cheeks began gathering Black gay men in Washington, D.C. for meditation, nutrition, and mutual support. The group he started — Us Helping Us, People Into Living — incorporated as a nonprofit on October 5, 1988, and became the oldest Black gay–founded and Black gay–led HIV organization in the U.S.15 Dr. Ron Simmons led it from 1992 to 2016, building it into one of the largest Black HIV organizations in the country and creating a barbershop outreach program and a help line for Black men who did not identify as gay.15

1989 — SisterLove, and the first women's HIV organization in the South

Dázon Dixon Diallo founded SisterLove in Atlanta in July 1989 — the first women's HIV/AIDS and reproductive justice organization in the southeastern United States.13 It grew out of the Women's AIDS Prevention Project, formed in 1987, and incorporated independently in 1992.13 Diallo described the founding logic in terms that have nothing to do with clinical protocols: Black women living with AIDS, she told a community publication, "have to know they are loved, because there was already so much hate for people with AIDS, and whatever happens to humankind happens worst to Black women."13

1993–1994 — Iris House opens, and Rae Lewis-Thornton is on the cover of Essence

In September 1993, Iris House opened in East Harlem as an agency built specifically to provide family-centered services to women of color living with HIV, named for the early activist Iris De La Cruz.16

A year later came the moment that changed the public face of the epidemic in Black America. Rae Lewis-Thornton had acquired HIV around 1983, learned her status in 1987 after donating blood, and progressed to an AIDS diagnosis in 1992. In December 1994 she appeared on the cover of Essence under the line "I'm young, I'm educated, I'm drug-free, and I'm dying of AIDS" — the first Black woman to tell the story of living with HIV in a magazine cover story.11 Her CD4 count was 84. She later won an Emmy for a Chicago television series about her life, and the Smithsonian's National Museum of African American History and Culture asked to catalogue the cover.11

Some activists pushed back on the "dying of AIDS" framing at the time, arguing for "living with AIDS" — an argument about language and dignity that the community was already having in 1994 and is still having now.11

1999 — the Black AIDS Institute

In May 1999, Phill Wilson founded what would become the Black AIDS Institute, originally named the African American AIDS Policy and Training Institute. It remains the only national HIV think tank focused exclusively on Black communities, and its founding motto stated the theory of change in seven words: "Our people, our problem, our solution."12

Wilson stepped down at the end of 2018. Raniyah Copeland, who joined in 2008, was named President and CEO in 2019.12 Toni Newman — a Black trans woman now at NMAC as Senior Director for the Coalition for Justice and Equality Across Movements — was interim CEO from October 2021 through September 2022.12

Black women — half the epidemic among women

In 2024, 7,752 women received an HIV diagnosis in the United States, 20% of the national total. Black women accounted for 52% of those diagnoses while making up about 13% of the female population. The diagnosis rate among Black women was 21.6 per 100,000 — more than three times the rate among Hispanic/Latina women (6.4) and about twelve times the rate among white women (1.8).1

Nearly all of this is heterosexual transmission. In CDC's estimates for Black women, around 85% of infections are attributed to heterosexual contact.1 Which means the story is about partnerships — and therefore about the structural forces that shape partnerships.

What "her risk" actually means

El-Sadr and colleagues were unusually direct about this. Writing about Black and Hispanic women, they described increased likelihood of acquiring HIV as "attributable in greater part to their vulnerable social and economic situations and their sexual networks than to their own risky behaviors."4 A woman in a monogamous relationship whose partner's network is dense with HIV faces real exposure without doing anything differently from a woman in a different zip code.

Two other realities shape prevention here. Intimate partner violence makes negotiating condom use, asking a partner to test, or disclosing a diagnosis genuinely unsafe for some women — which is why a discreet, partner-independent option matters so much. And disclosure carries distinct social costs, from custody and housing to church and family standing.

The sisterhood care model

Black women have built important institutions alongside clinical services. SisterLove and Iris House provide examples of community-led support addressing needs such as reproductive health, childcare, nutrition, and care access. The sources here describe their models; they do not establish that one model is superior to all clinical outreach.1316

Black gay and bisexual men — the highest projected lifetime risk in the country

Male-to-male sexual contact accounted for 25,129 diagnoses, or 65%, in CDC’s provisional 2024 report. The often-cited 1-in-2 lifetime estimate for Black men who have sex with men comes from an analysis presented in 2016 using 2009–2013 data. It should not be read as a current forecast for an individual.13

Everything in the "structure, not behavior" section applies here most sharply, because this is where the behavioral hypothesis was tested most thoroughly and failed most clearly. Millett's earlier 2007 meta-analysis in AIDS found Black gay and bisexual men reported fewer partners (OR 0.64) and less substance use (OR 0.71) than white peers, while Black participants living with HIV were less likely to report being on antiretroviral therapy (OR 0.43).6 Fewer partners, less substance use, less treatment. That is an access story from start to finish.

Three specific structural pressures

• Network context. In a 2011–2013 North Carolina partner-services investigation, 41% of named partners and social contacts already had diagnosed HIV. This selected investigation was not a population sample, and social proximity itself does not transmit HIV.7
• Insurance and treatment initiation. Lower coverage and roughly 60% lower odds of having started combination therapy mean higher community viral load, feeding back into network transmission.6
• Youth concentration. Among males aged 13–24, Black males were 47% of diagnoses attributed to male-to-male sexual contact in 2024 — the burden lands before most people have stable insurance or a regular provider.1

The mental health toll is part of the epidemiology

Black gay and bisexual men may face racism, homophobia, and isolation that complicate access to support. THRIVE SS’s community-led model combines online, in-person, and social support. Published work describes its development and community priorities; that does not prove superiority over clinical outreach or guarantee improved viral suppression for each participant.14

Black trans women — the sharpest disparity in the data

CDC’s 2019–2020 NHBS study recruited 1,608 transgender women in seven urban areas. In that sample, 42% tested positive for HIV: 62% of Black participants, 35% of Hispanic/Latina participants, and 17% of White participants. These are serious disparities within the study, but the sample does not establish national prevalence or a ranking against every U.S. population.8

The same recruited urban sample found nearly two-thirds of participants living at or below the poverty level and 42% reporting homelessness in the prior year. Those findings describe substantial material needs among participants and should not be treated as representative of every transgender woman.8

Naming the actual mechanism

Poverty, housing instability, employment discrimination, survival economies, and violence can interact with prevention access and exposure; no single factor explains every infection. For a person who cannot get hired, cannot keep housing, and is unsafe walking home, "prevention counseling" is not the binding constraint. Anti-trans violence falls disproportionately on Black trans women, and the fear it produces is itself a barrier to sitting in a waiting room and filling out a form with your legal name on it.

What works tends to look like this: gender-affirming care and HIV care in the same building, from the same team, with hormones and HIV treatment prescribed together rather than in competition; trans staff at the front desk and in leadership; housing and legal support treated as clinical services. Community-building matters too — Black Trans Femmes in the Arts, founded by Jordyn Jay in 2019 and based in Brooklyn, organizes around Black trans femme joy rather than only around tragedy.16 Joy, creativity, and belonging deserve room alongside remembrance and practical support; this is not a claim that one kind of community activity has been proven to produce better clinical outcomes.

Black youth — the burden lands early

People aged 25–34 accounted for 14,183 diagnoses in 2024, 37% of the national total — the largest age band.1 The more telling figure is in the youngest group: among males aged 13–24, Black males were 47% of diagnoses attributed to male-to-male sexual contact.1 Nearly half the youth burden in that category falls on one group.

Several structural features stack against Black adolescents and young adults:

• Sex education gaps. Many Southern states, where the burden is concentrated, do not require medically accurate or inclusive sex education — the highest-burden geography gets the least information.
• Insurance churn. Ages 18–26 is when coverage is least stable, right when diagnoses spike.
• Consent and confidentiality. A young person who fears a parent seeing an insurance statement may skip testing or PrEP entirely. Confidential minor-consent pathways change uptake.
• PrEP is rarely offered. Youth are the least likely to have PrEP raised by a clinician, despite carrying a large share of new diagnoses.17

Ballroom as public health infrastructure

One of the most durable protective structures for Black and Latino LGBTQ+ young people was not built by a health department. The ballroom scene — its house system, chosen family, and decades of institutional memory — has functioned as a peer network, a housing referral system, an HIV testing venue, and a stigma buffer since long before public health thought to fund it. When testing and PrEP navigation are embedded in balls and houses, they reach young people who will never walk into a county clinic. We cover this in depth on HIV & the ballroom scene.

The care cascade — where the gap actually opens

The HIV care continuum runs from diagnosis to linkage to care to retention to viral suppression. It is where structural disadvantage becomes measurable clinical harm, and where the most tractable leverage sits, because each step is a system behavior that can be redesigned.

CDC's most recent national figures, covering 2024 outcomes, show: 83.1% of people newly diagnosed were linked to care within one month; 71.1% achieved viral suppression within six months of diagnosis; 77.0% of the 1,103,895 people living with diagnosed HIV received any care during 2024; 56% were retained in care; and 68.5% were virally suppressed during the year.2

Broken out by race, Black people had a linkage-to-care rate of 80.8% within one month — among the lowest of any group reported.2 Two and a half points below the national average sounds small until you multiply it by the number of people involved and follow it forward: late linkage predicts late suppression, which predicts worse long-term health.

Why people fall out — and it is almost never motivation

The reasons are consistent and boring, which is good news, because boring problems have known fixes:

• Transportation. A clinic reachable only by two buses loses people who want to be there.
• Appointment structure. Business-hours-only clinics select against hourly workers.
• Insurance churn. In non-expansion states, a person can be over the Medicaid threshold and under the subsidy threshold at once.
• Housing instability. Medication storage, mail, and reminders all assume an address.
• Experiences of disrespect. One bad encounter with a clinician can end a care relationship, and the mistrust that follows is rational.

Note what is not on that list: unwillingness to take medication. Adherence is downstream of the items above, not an independent character trait — which is why programs that pay for rides, extend hours, and employ peer navigators outperform programs that send reminder letters.

Mistrust is earned — and trust is buildable

Tuskegee is not a metaphor. From 1932 to 1972 the U.S. Public Health Service ran a syphilis study on Black men in Alabama in which effective treatment was withheld. That happened, it was federal, and it ended within living memory.

But treating mistrust as a historical artifact misses the point, because an older study helps show how researchers measured it. Giselle Corbie-Smith and colleagues surveyed 527 African American and 382 white respondents: 41.7% of African American respondents versus 23.4% of white respondents did not trust that their physician would fully explain research participation, and 45.5% versus 34.8% believed their physician had exposed them to unnecessary risk. After controlling for sociodemographic factors, race remained associated with higher distrust (prevalence odds ratio 4.7, 95% CI 2.9–7.7).9

The Corbie-Smith study was published in 2002. Its adjusted association does not by itself identify a cause or describe current attitudes. Its relevance here is the need to take concerns seriously and build trustworthy research and clinical relationships.

What actually closes the gap

Trust is not built by asserting it. It is built structurally:

• Peer navigators and community health workers. A person who shares your diagnosis, neighborhood, and language carries credibility no brochure can manufacture. THRIVE SS built a tiered model on this premise — online support, in-person support, and friendship-level social support — and grew past 3,500 members nationwide, roughly 940 in Atlanta.14
• Black-led clinics and organizations. When leadership, staff, and board reflect the community, mistrust has less to work with. Us Helping Us runs two sites, a certified freestanding mental health clinic, syringe services, and a status-neutral food pantry and clothing closet.15
• Barbershops, salons, and churches. Ron Simmons's barbershop program at Us Helping Us worked because it went where Black men already were, on their terms.15
• Transparency about research. Naming what a study will and will not do, who pays, and what happens to your data — every time.

PrEP — the biggest single gap, and the newest opening

AIDSVu compares 2024 PrEP use with 2022 HIV diagnoses. Black people represented 15% of PrEP users and 38% of diagnoses in those respective datasets; White people 63% and 24%; Hispanic/Latino people 18% and 32%. These are shares of users and diagnoses, not the percentage of each population’s PrEP need that has been met.17

Read those columns together: the group with the highest burden has the lowest share of the most effective prevention tool available. That is not a preference gap. It is a prescribing, insurance, and access gap. (CDC has paused publication of PrEP coverage estimates by race while it revises methodology, and currently advises against citing specific coverage percentages, so the AIDSVu user-share figures are the clearer comparison right now.17)

Long-acting PrEP works — and it was proven with Black participants

HPTN 083 tested injectable cabotegravir every eight weeks against daily oral tenofovir/emtricitabine among cisgender men and transgender women who have sex with men. The injectable was superior: 13 infections versus 39, a hazard ratio of 0.34 (95% CI 0.18–0.62) — a 66% reduction.18

The detail that matters here: of the 1,698 U.S. participants, 845 — 49.8% — identified as Black, and efficacy among U.S. Black participants was a pre-specified subgroup analysis, not an afterthought. In that subgroup the hazard ratio was 0.28 (95% CI 0.10–0.83): 4 infections per 688 person-years on injectable cabotegravir versus 15 per 715 on daily oral PrEP.18 Long-acting PrEP was not proven elsewhere and extrapolated to Black communities. It was demonstrated in them, by design.

Twice-yearly PrEP arrived in 2025

FDA approved twice-yearly lenacapavir PrEP in June 2025 for adults and adolescents weighing at least 35 kg. CDC’s recommendation describes strong prevention efficacy in PURPOSE 1 and PURPOSE 2. The regimen requires initiation doses, HIV testing before use and during follow-up, and injections on schedule; trial percentages should not be read as a guarantee of permanent protection.^[26]19

Twice-yearly dosing can reduce some of the structural barriers described earlier: no daily pill to store in unstable housing, no monthly pharmacy trip, no bottle for a partner or parent to find. For someone experiencing housing instability or intimate partner violence, that is not a convenience feature — it is the difference between possible and impossible.

Access remains a practical question. Insurance coverage, PrEP assistance programs, clinic capacity, and the costs of visits and testing can determine whether someone receives long-acting prevention. Ryan White/ADAP funds serve eligible people with HIV; they are not a general PrEP benefit for people without HIV. A clinic may provide PrEP through other funding.^[23]19

The Southern epidemic

The South carried 51% of new diagnoses, 53% of HIV-related deaths, and 46% of people living with diagnosed HIV in 2024.1 The federal Ending the HIV Epidemic initiative concentrates resources in 57 priority jurisdictions: 48 counties, Washington D.C., and San Juan, Puerto Rico — more than half of all diagnoses at the 2019 launch — plus seven states with a substantial share of diagnoses in rural areas.20

Those seven states are Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina.20 These states were selected for substantial rural HIV burden. Their selection does not mean they lacked any priority county, and they should not all be counted as Southern states.

What makes the South structurally different

• Medicaid non-expansion. Several high-burden Southern states have not expanded Medicaid, leaving a coverage gap that falls hardest on low-income adults.
• Rural distance. In the rural-burden EHE states, the nearest HIV specialist may be a hundred miles away.
• Provider shortage. Shortage designations cluster in the same counties as the highest diagnosis rates.
• Stigma density. In smaller communities, confidentiality is harder and the cost of being seen entering a sexual health clinic is higher.

Every one of these is a policy variable. None is a behavior. Our companion piece on HIV in the South covers the regional politics and funding structure in detail.

The organizations doing the work

Any honest account of progress here starts with Black-led organizations, which built most of the effective models long before they were funded to.

Florida specifics

Florida is not a footnote to this story. It holds seven of the 48 Ending the HIV Epidemic priority counties — Broward, Duval, Hillsborough, Miami-Dade, Orange, Palm Beach, and Pinellas — a substantial share of the priority counties.20

The Florida Department of Health's most recent state HIV epidemiology slide set reports 4,719 adult HIV diagnoses in 2023. Black Floridians were 45% of those diagnoses and 51% of AIDS diagnoses, while making up 15% of the adult population.21

The rate comparisons are sharper still. In 2023, the adult HIV diagnosis rate per 100,000 was 108.0 among Black men versus 15.5 among white men — a ratio of 6.9 to 1. Among women it was 41.6 among Black women versus 3.1 among white women — 13.2 to 1 in the state report.21

Prevalence tells the same story. Florida reports that roughly 1 in 177 adults in the state were living with HIV in 2023 — but 1 in 64 Black adults, against 1 in 336 white adults. Black Floridians accounted for 55,117 people living with HIV, 42% of the state total.21 Separately, the 2022–2026 integrated plan’s 2021 epidemiologic snapshot records viral suppression at 64% among Black Floridians living with HIV, against 77% among white and 71% among Hispanic/Latino Floridians — a thirteen-point cascade gap inside one state system.21

What to actually do

If you were just diagnosed

• Ask about starting treatment promptly. NIH recommends ART as soon as possible after diagnosis. Same-day treatment is often feasible, but clinical assessment and certain opportunistic infections can change timing.^[25]
• Ask for a peer navigator by name. If the clinic has one, use them. If not, ask which nearby organization does.
• Plan disclosure safely. You can decide whom to tell socially, while partner-disclosure duties before sex depend on local law. Ask for confidential legal advice if you are unsure.
• Find one Black-led organization to connect with — THRIVE SS, SisterLove, Us Helping Us, Iris House, or a local equivalent. Being around people who share your diagnosis and your context changes the first year enormously.14

If you are HIV negative and want to stay that way

• Ask about PrEP directly, and ask about all three forms: daily oral, every-two-months injectable, and twice-yearly lenacapavir.1819
• If your provider does not bring it up, that is a provider gap, not your gap. The 15%-of-PrEP-users figure is largely a prescribing failure.17
• Change providers if you need to. Ryan White clinics, federally qualified health centers, and Black-led community clinics are usually most fluent in this conversation.
• Test on a schedule, not on a scare. Routine testing catches HIV early, when treatment works best.

If you are living with HIV and in care

• Undetectable means untransmittable. A sustained undetectable viral load means you do not transmit HIV sexually — which is why treatment access is prevention policy.
• Name the practical obstacles out loud. Rides, hours, copays, and pharmacy distance are things clinics can often solve.
• Ask about long-acting treatment. If daily pills are the hard part, injectable options exist and are worth a conversation.

If you are advocating

• Fund Black-led organizations directly, as general operating support rather than restricted project money. The models on this page were built by these groups with less money than the institutions that later adopted them.
• Push on Medicaid expansion and the EHE funding pipeline. Ask specifically whether EHE dollars in your jurisdiction reach Black-led organizations or stop at large institutional grantees.20
• Insist on lenacapavir access parity. The next two years determine whether twice-yearly PrEP closes the gap or widens it.19
• Correct the framing every time you hear it. When someone calls a community "at risk," ask which structure they mean. Networks, incarceration, redlining, insurance, provider supply — name the mechanism. Framing determines funding.